Product
rhGH
3 clinical trials
5 indications
Indication
Idiopathic Short StatureIndication
Small for Gestational AgeIndication
Turner syndromeIndication
Growth DisordersIndication
Growth Hormone DeficiencyClinical trial
A Multicenter, Randomized, Open-label, Positive-controlled Phase 2 Study to Explore the Optimal Dose of Y- Shaped Pegylated Recombinant Growth Hormone (YPEG-rhGH) in Children With Short Stature (ISS, SGA, TS)Status: Completed, Estimated PCD: 2023-10-23
Clinical trial
Comparison of Somavaratan (VRS-317), a Long-acting Human Growth Hormone, to Daily rhGH in a Phase 3, Randomized, One-year, Open-label, Multi-center, Non-inferiority Trial in Pre-pubertal Children With Growth Hormone DeficiencyStatus: Completed, Estimated PCD: 2017-08-23
Clinical trial
Evaluation of Vesiculogenesis in Children With GH Deficiency Undergoing Hormone Replacement TherapyStatus: Recruiting, Estimated PCD: 2023-12-31